Drug or treatment

Pozelimab clinical trials

• 6Clinical trials
• 28Countries

Newest trials

All recruiting trials (6)

• Eye injection of pozelimab for geographic atrophy in adults

  This study will test whether injections of pozelimab into the eye are safe and well tolerated in adults with geographic atrophy from age-related macular degeneration.

  Recruiting at 9 sites Phase 1 Regeneron Pharmaceuticals · Lakewood, Colorado and 8 other locations · NCT07230834

• Pozelimab + cemdisiran for adults with PNH whose current treatment isn't working

  This trial tests whether combining pozelimab and cemdisiran can better reduce hemolysis in adults with PNH whose C5 inhibitor treatment isn’t controlling their disease.

  Recruiting at 20 sites Phase 3 Regeneron Pharmaceuticals · Ribeirão Preto, São Paulo and 19 other locations · NCT07154745

• Pozelimab safety in children 1 to 5 with CHAPLE disease

  This trial will test whether pozelimab is safe and tolerable in children ages 1 to 5 who have CHAPLE disease.

  Recruiting Phase 4 Regeneron Pharmaceuticals · Istanbul · NCT07142343

• Investigating a new treatment for geographic atrophy in age-related macular degeneration

  This study is testing a new treatment using two drugs to see if they can slow down the worsening of geographic atrophy in adults with age-related macular degeneration.

  Recruiting at 220 sites Phase 3 Regeneron Pharmaceuticals · Chandler, Arizona and 232 other locations · NCT06541704

• Combination therapy for sporadic inclusion body myositis

  This study is testing a new combination treatment with Pozelimab and Cemdisiran to see if it can help people with sporadic inclusion body myositis feel better.

  Recruiting at 2 sites Early Phase 1 Austin Neuromuscular Center · Austin, Texas and 1 other locations · NCT06479863

• Long-term treatment for patients with paroxysmal nocturnal hemoglobinuria using pozelimab and cemdisiran

  This study is testing a new combination of two experimental drugs, pozelimab and cemdisiran, to see if they can safely help adults with paroxysmal nocturnal hemoglobinuria over a long period of time.

  Recruiting at 48 sites Phase 3 Regeneron Pharmaceuticals · Curitiba, Jardim Santo Andre and 49 other locations · NCT05744921

Quick answers

How many clinical trials of Pozelimab are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 28 countries. The most sites are in Canada (3 trials), Italy (3 trials), Poland (3 trials), Spain (3 trials), Turkey (Türkiye) (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 1: 1, Phase 4: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →